Monovisc is a viscosupplement administered through a single injection, specifically designed to address joint pain resulting from osteoarthritis. Osteoarthritis often leads to a decrease in natural hyaluronan levels and a decline in its quality, resulting in joint irritation, inflammation, pain, and stiffness. By introducing Monovisc, a gel substance containing the maximum dosage of 88mg of hyaluronan (HA), into the affected joint, it acts as both a lubricant and pain reliever. The administration of Monovisc involves a direct injection into the knee joint.
The package includes:
- 1 Syringe x 4ml per pack
- Ingredients of the product:
- Partially cross-linked sodium Hyaluronate (NaHA)
- 88 mg Hyaluronan
- 36 mg Sodium Chloride
The advantages of utilizing of Monovisc:
- Treatment involving a single injection
- Instantaneous alleviation of pain
What is the duration of the results?
Monovisc has the potential to offer pain relief for a period of up to 6 months. The duration of relief can vary from person to person, with some individuals experiencing immediate relief following the injection.